BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21112438)

  • 1. Accelerometry and its association with objective markers of walking limitations in ambulatory adults with multiple sclerosis.
    Motl RW; Dlugonski D; Suh Y; Weikert M; Fernhall B; Goldman M
    Arch Phys Med Rehabil; 2010 Dec; 91(12):1942-7. PubMed ID: 21112438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerometry as a measure of walking behavior in multiple sclerosis.
    Motl RW; Pilutti L; Sandroff BM; Dlugonski D; Sosnoff JJ; Pula JH
    Acta Neurol Scand; 2013 Jun; 127(6):384-90. PubMed ID: 23240822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of patient-reported outcomes of physical activity and accelerometry in people with multiple sclerosis and ambulatory impairment: A cross-sectional study.
    Wanitschek A; Seebacher B; Muehlbacher A; Brenneis C; Ehling R
    Mult Scler Relat Disord; 2024 May; 85():105532. PubMed ID: 38452648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further validation of multiple sclerosis walking scale-12 scores based on spatiotemporal gait parameters.
    Pilutti LA; Dlugonski D; Sandroff BM; Suh Y; Pula JH; Sosnoff JJ; Motl RW
    Arch Phys Med Rehabil; 2013 Mar; 94(3):575-8. PubMed ID: 22960049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gait Variability and Energy Cost of Oveground Walking in Persons With Multiple Sclerosis: A Cross-Sectional Study.
    Sebastião E; Bollaert RE; Hubbard EA; Motl RW
    Am J Phys Med Rehabil; 2018 Sep; 97(9):646-650. PubMed ID: 29595583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerometry in persons with multiple sclerosis: measurement of physical activity or walking mobility?
    Weikert M; Motl RW; Suh Y; McAuley E; Wynn D
    J Neurol Sci; 2010 Mar; 290(1-2):6-11. PubMed ID: 20060544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis.
    Learmonth YC; Motl RW; Sandroff BM; Pula JH; Cadavid D
    BMC Neurol; 2013 Apr; 13():37. PubMed ID: 23617555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying gait impairment in multiple sclerosis using GAITRite technology.
    Sosnoff JJ; Weikert M; Dlugonski D; Smith DC; Motl RW
    Gait Posture; 2011 May; 34(1):145-7. PubMed ID: 21531562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxygen Cost During Mobility Tasks and Its Relationship to Fatigue in Progressive Multiple Sclerosis.
    Devasahayam AJ; Kelly LP; Wallack EM; Ploughman M
    Arch Phys Med Rehabil; 2019 Nov; 100(11):2079-2088. PubMed ID: 31026463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying six-minute walk induced gait deterioration with inertial sensors in multiple sclerosis subjects.
    Engelhard MM; Dandu SR; Patek SD; Lach JC; Goldman MD
    Gait Posture; 2016 Sep; 49():340-345. PubMed ID: 27479220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple Sclerosis Walking Scale-12 and oxygen cost of walking.
    Motl RW; Dlugonski D; Suh Y; Weikert M; Agiovlasitis S; Fernhall B; Goldman M
    Gait Posture; 2010 Apr; 31(4):506-10. PubMed ID: 20226676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores.
    Motl RW; Cadavid D; Sandroff BM; Pilutti LA; Pula JH; Benedict RH
    J Neurol Sci; 2013 Dec; 335(1-2):169-73. PubMed ID: 24104065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of the dynamic gait index in people with multiple sclerosis.
    Forsberg A; Andreasson M; Nilsagård YE
    Phys Ther; 2013 Oct; 93(10):1369-76. PubMed ID: 23641026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further validation of the Six-Spot Step Test as a measure of ambulation in multiple sclerosis.
    Sandroff BM; Motl RW; Sosnoff JJ; Pula JH
    Gait Posture; 2015 Jan; 41(1):222-7. PubMed ID: 25455207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerometry is associated with walking mobility, not physical activity, in persons with multiple sclerosis.
    Weikert M; Suh Y; Lane A; Sandroff B; Dlugonski D; Fernhall B; Motl RW
    Med Eng Phys; 2012 Jun; 34(5):590-7. PubMed ID: 21968005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation analysis of visual analogue scale and measures of walking ability in multiple sclerosis patients.
    Filipović Grčić P; Matijaca M; Bilić I; Džamonja G; Lušić I; Čaljkušić K; Čapkun V
    Acta Neurol Belg; 2013 Dec; 113(4):397-402. PubMed ID: 23494833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerometer cut-points derived during over-ground walking in persons with mild, moderate, and severe multiple sclerosis.
    Sandroff BM; Riskin BJ; Agiovlasitis S; Motl RW
    J Neurol Sci; 2014 May; 340(1-2):50-7. PubMed ID: 24635890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Turning is an important marker of balance confidence and walking limitation in persons with multiple sclerosis.
    Adusumilli G; Lancia S; Levasseur VA; Amblee V; Orchard M; Wagner JM; Naismith RT
    PLoS One; 2018; 13(6):e0198178. PubMed ID: 29879144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamometer-based measure of spasticity confirms limited association between plantarflexor spasticity and walking function in persons with multiple sclerosis.
    Kremer TR; Van Dillen LR; Wagner JM
    J Rehabil Res Dev; 2014; 51(6):975-84. PubMed ID: 25356797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Confirmation and extension of the validity of the Multiple Sclerosis Walking Scale-12 (MSWS-12).
    Motl RW; Snook EM
    J Neurol Sci; 2008 May; 268(1-2):69-73. PubMed ID: 18061618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.